Evidence map›Paper›PMID 28779833›Full record

ReviewInfectious disease clinics of North America2017

High-Containment Pathogen Preparation in the Intensive Care Unit.

Brian T Garibaldi, Daniel S Chertow

Abstract readReview
In one paragraph

Review in Infectious disease clinics of North America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Ethical Preparedness for U.S. Biocontainment Units.Journal of bioethical inquiry · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Brian T GaribaldiDivision of Pulmonary and Critical Care, Johns Hopkins University School of Medicine, 1830 East Monument Street, 5th Floor, Baltimore, MD 21205, USA.
Daniel S ChertowCritical Care Medicine Department, Clinical Center, National Institutes of Health, 10 Center Drive, Room 2C-145, Bethesda, MD 20892-1662, USA. Electronic address: chertowd@cc.nih.gov.

Funding

Clinical and Molecular Features of Ebola Virus DiseaseZIACL009024 · CLC · CLINICAL CENTER · PI CHERTOW, DANIEL S · 2017 to 2025
$0k
Intramural NIH HHS Z99 CL999999
6 · The paper itself

Abstract

The recent Ebola virus disease outbreak highlighted the need to build national and worldwide capacity to provide care for patients with highly infectious diseases. Specialized biocontainment units were successful in treating several critically ill patients with Ebola virus disease both in the United States and Europe. Several key principles underlie the care of critically ill patients in a high-containment environment. Environmental factors, staffing, equipment, training, laboratory testing, procedures, and waste management each present unique challenges. A multidisciplinary approach is key to developing effective systems and protocols to maintain the safety of patients, staff, and communities.

Indexed as

Communicable DiseasesContainment of BiohazardsDisease ManagementIntensive Care UnitsCommunicable Disease ControlDisease OutbreaksHealth PersonnelHemorrhagic Fever, EbolaHumansInfection ControlPatient IsolationUnited StatesBiocontainment unitHigh-containment pathogensPreparednessSupportive critical care

Identifiers

PMID28779833
PMCPMC5568084

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.